These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26198729)

  • 1. Expression and Significances of MTSS1 in Pancreatic Cancer.
    Zhou L; Li J; Shao QQ; Guo JC; Liang ZY; Zhou WX; Zhang TP; You L; Zhao YP
    Pathol Oncol Res; 2016 Jan; 22(1):7-14. PubMed ID: 26198729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of metastasis suppressor 1(MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer.
    Liu K; Wang G; Ding H; Chen Y; Yu G; Wang J
    BMC Cancer; 2010 Aug; 10():428. PubMed ID: 20712855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MTSS1 overexpression correlates with poor prognosis in colorectal cancer.
    Wang D; Xu MR; Wang T; Li T; Zhu Jw
    J Gastrointest Surg; 2011 Jul; 15(7):1205-12. PubMed ID: 21562916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and clinical significance of miR-23a and metastasis suppressor 1 in colon carcinoma].
    Tang HL; Deng M; Liao QJ; Zeng X; Zhou XT; Su Q
    Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):28-32. PubMed ID: 22455847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer.
    Parr C; Jiang WG
    Eur J Cancer; 2009 Jun; 45(9):1673-83. PubMed ID: 19328678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma.
    Du P; Wang S; Tang X; An C; Yang Y; Jiang WG
    Anticancer Res; 2017 Aug; 37(8):4499-4505. PubMed ID: 28739745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of MTSS1 expression is an independent prognostic factor for Hilar cholangiocarcinoma.
    Wang F; Liu Y; Zhang H
    Pathol Oncol Res; 2013 Oct; 19(4):815-20. PubMed ID: 23852458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of MTSS1 results in increased metastatic potential in pancreatic cancer.
    Zeleniak AE; Huang W; Brinkman MK; Fishel ML; Hill R
    Oncotarget; 2017 Mar; 8(10):16473-16487. PubMed ID: 28146435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of c-fos was associated with clinicopathologic characteristics and prognosis in pancreatic cancer.
    Guo JC; Li J; Zhao YP; Zhou L; Cui QC; Zhou WX; Zhang TP; You L
    PLoS One; 2015; 10(3):e0120332. PubMed ID: 25789763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients.
    Guo S; Jing W; Hu X; Zhou X; Liu L; Zhu M; Yin F; Chen R; Zhao J; Guo Y
    Int J Cancer; 2014 Mar; 134(6):1369-78. PubMed ID: 24037692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A reciprocal feedback of Myc and lncRNA MTSS1-AS contributes to extracellular acidity-promoted metastasis of pancreatic cancer.
    Hu Y; Wang F; Xu F; Fang K; Fang Z; Shuai X; Cai K; Chen J; Hu P; Chen D; Xu P; Hu C; Zeng Z; Zhong J; Li W; Tang J; Huang M; Zhao Y; Wang C; Zhao G
    Theranostics; 2020; 10(22):10120-10140. PubMed ID: 32929338
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic significance of epidermal growth factor-like domain 7 in pancreatic cancer.
    Zhou L; Li J; Zhao YP; Guo JC; Cui QC; Zhou WX; Zhang TP; Wu WM; You L; Shu H
    Hepatobiliary Pancreat Dis Int; 2014 Oct; 13(5):523-8. PubMed ID: 25308363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN-Dependent Stabilization of MTSS1 Inhibits Metastatic Phenotype in Pancreatic Ductal Adenocarcinoma.
    Zeleniak AE; Huang W; Fishel ML; Hill R
    Neoplasia; 2018 Jan; 20(1):12-24. PubMed ID: 29175021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MTSS1 suppresses cell migration and invasion by targeting CTTN in glioblastoma.
    Zhang S; Qi Q
    J Neurooncol; 2015 Feb; 121(3):425-31. PubMed ID: 25385572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein.
    Sheng W; Dong M; Chen C; Li Y; Liu Q; Dong Q
    Oncotarget; 2017 Feb; 8(9):14359-14373. PubMed ID: 27092875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significance.
    Xue YZ; Sheng YY; Liu ZL; Wei ZQ; Cao HY; Wu YM; Lu YF; Yu LH; Li JP; Li ZS
    Tumour Biol; 2013 Apr; 34(2):895-9. PubMed ID: 23247867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of MTSS1 expression is an independent prognosticator in squamous cell carcinoma of the lung.
    Kayser G; Csanadi A; Kakanou S; Prasse A; Kassem A; Stickeler E; Passlick B; Zur Hausen A
    Br J Cancer; 2015 Mar; 112(5):866-73. PubMed ID: 25625275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.
    Yan TT; Fu XL; Li J; Bian YN; Liu DJ; Hua R; Ren LL; Li CT; Sun YW; Chen HY; Fang JY; Hong J
    Oncotarget; 2015 Nov; 6(35):37028-42. PubMed ID: 26498693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.